Subcortical Atrophy Is Associated with Cognitive Impairment in Mild Parkinson Disease: A Combined Investigation of Volumetric Changes, Cortical Thickness, and Vertex-Based Shape Analysis

BACKGROUND AND PURPOSE: The involvement of subcortical deep gray matter and cortical thinning associated with mild Parkinson disease remains poorly understood. We assessed cortical thickness and subcortical volumes in patients with Parkinson disease without dementia and evaluated their associations with cognitive dysfunction. MATERIALS AND METHODS: The study included 90 patients with mild Parkinson disease without dementia. Neuropsychological assessments classified the sample into patients with mild cognitive impairment (n = 25) and patients without cognitive impairment (n = 65). Volumetric data for subcortical structures were obtained by using the FMRIB Integrated Registration and Segmentation Tool while whole-brain, gray and white matter volumes were estimated by using Structural Image Evaluation, with Normalization of Atrophy. Vertex-based shape analyses were performed to investigate shape differences in subcortical structures. Vertex-wise group differences in cortical thickness were also assessed. Volumetric comparisons between Parkinson disease with mild cognitive impairment and Parkinson disease with no cognitive impairment were performed by using ANCOVA. Associations of subcortical structures with both cognitive function and disease severity were assessed by using linear regression models. RESULTS: Compared with Parkinson disease with no cognitive impairment, Parkinson disease with mild cognitive impairment demonstrated reduced volumes of the thalamus (P = .03) and the nucleus accumbens (P = .04). Significant associations were found for the nucleus accumbens and putamen with performances on the attention/working memory domains (P < .05) and nucleus accumbens and language domains (P = .04). The 2 groups did not differ in measures of subcortical shape or in cortical thickness. CONCLUSIONS: Patients with Parkinson disease with mild cognitive impairment demonstrated reduced subcortical volumes, which were associated with cognitive deficits. The thalamus, nucleus accumbens, and putamen may serve as potential biomarkers for Parkinson disease–mild cognitive impairment.

[1]  J. Grafman,et al.  Clock Drawing in Alzheimer's Disease , 1989, Journal of the American Geriatrics Society.

[2]  A. Ginestroni,et al.  A Whole-Brain Analysis in De Novo Parkinson Disease , 2008, American Journal of Neuroradiology.

[3]  M Emre,et al.  Attentional deficits affect activities of daily living in dementia-associated with Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[5]  Mark Jenkinson,et al.  The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis , 2012, Human brain mapping.

[6]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[7]  Nuria Bargallo,et al.  Assessment of cortical degeneration in patients with Parkinson's disease by voxel‐based morphometry, cortical folding, and cortical thickness , 2012, Human brain mapping.

[8]  P. Calabresi,et al.  A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine–acetylcholine synaptic balance , 2006, The Lancet Neurology.

[9]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[10]  K. Leenders,et al.  Putamen FDOPA uptake and its relationship tot cognitive functioning in PD , 2006, Journal of the Neurological Sciences.

[11]  I. McKeith,et al.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. , 2004, Brain : a journal of neurology.

[12]  C. Summerfield,et al.  Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. , 2005, Archives of neurology.

[13]  Chul Hyoung Lyoo,et al.  Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia , 2010, Movement disorders : official journal of the Movement Disorder Society.

[14]  A. Owen.  Cognitive Dysfunction in Parkinson’s Disease: The Role of Frontostriatal Circuitry , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[15]  References , 1971 .

[16]  E. Tolosa,et al.  Progression of cortical thinning in early Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[17]  Robert Zivadinov,et al.  Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.

[18]  The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations , 2003, Movement disorders : official journal of the Movement Disorder Society.

[19]  B. Schmand,et al.  Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.

[20]  Mojtaba Zarei,et al.  Cortical thinning is associated with disease stages and dementia in Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  J. Kim,et al.  Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia. , 2014, Parkinsonism & related disorders.

[22]  I. Veer,et al.  Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study , 2008, Brain : a journal of neurology.

[23]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[24]  J. Growdon,et al.  Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease , 1989, Annals of neurology.

[25]  M. Herrero,et al.  Functional anatomy of thalamus and basal ganglia , 2002, Child’s Nervous System.

[26]  J. Rinne,et al.  Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra , 1989, Annals of neurology.

[27]  K. Jellinger.  The association of incident dementia with mortality in PD , 2003, Neurology.

[28]  R. Camicioli,et al.  Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease , 2008, Neurobiology of Aging.

[29]  J. Zhong,et al.  Gray matter atrophy in Parkinson’s disease with dementia: evidence from meta-analysis of voxel-based morphometry studies , 2013, Neurological Sciences.

[30]  Y. Itoyama,et al.  Corticolimbic gray matter loss in Parkinson’s disease without dementia , 2010, European journal of neurology.

[31]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[32]  Jan Kassubek,et al.  Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. , 2005, Cerebral cortex.

[33]  M Emre,et al.  Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[34]  Nagaendran Kandiah,et al.  Cognitive decline in early Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[35]  Robert Zivadinov,et al.  Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients , 2013, Multiple sclerosis.

[36]  I. McKeith,et al.  MRI Study of Caudate Nucleus Volume in Parkinson’s Disease with and without Dementia with Lewy Bodies and Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[37]  C. Adler,et al.  MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI , 2011, Movement disorders : official journal of the Movement Disorder Society.

[38]  D. Royall,et al.  The FAB: A frontal assessment battery at bedside , 2001, Neurology.

[39]  Dagmar Verbaan,et al.  The MoCA: Well-suited screen for cognitive impairment in Parkinson disease , 2011, Neurology.

[40]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[41]  C. Derouesné.  [Mini-mental state examination]. , 2001, Revue neurologique.

[42]  A. Levey,et al.  Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. , 2010, Parkinsonism & related disorders.

[43]  C. Summerfield,et al.  Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia , 2005, Movement disorders : official journal of the Movement Disorder Society.

[44]  H. Shill,et al.  Defining mild cognitive impairment in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[45]  Chantal E Stern,et al.  Focal cortical and subcortical atrophy in early Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[46]  Robert Zivadinov,et al.  Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis A case-control study , 2012, NeuroImage.

[47]  Turi O. Dalaker,et al.  Gray matter correlations of cognition in incident Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[48]  U. Bonuccelli,et al.  Mild cognitive impairment and cognitive reserve in Parkinson's disease. , 2011, Parkinsonism & related disorders.

[49]  G. Goldenberg,et al.  Basal forebrain amnesia: does the nucleus accumbens contribute to human memory? , 1999, Journal of neurology, neurosurgery, and psychiatry.

[50]  Joseph V. Hajnal,et al.  Regional changes in thalamic shape and volume with increasing age , 2012, NeuroImage.

[51]  M. A. Buchem,et al.  Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study , 2012, Neurobiology of Aging.

[52]  Hae-Jeong Park,et al.  The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status , 2011, Movement disorders : official journal of the Movement Disorder Society.

[53]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.